NKp46+CD3+ cells as a Novel Target for Vaccines Against Bovine TB
What the buyer wrote
The Morrison and Vordermeier laboratories have recently identified a novel NKp46+CD3+ non-conventional T-cell population in cattle and demonstrated that a subset of these cells recognise phosphatidylinositol mannosides (PIMs - a group of membrane bound lipids) from Mb. In this project we propose to i) examine NKp46+CD3+ T-cell responses during a BCG-immunisation/Mb-challenge study so as to gain some insights into the role of lipid-specific T-cells in bTB and ii) explore the breadth of lipids from TB that act as antigens for bovine T-cells and evaluate their potential as vaccine antigens. Specifically we aim to address the following questions: 1. What are the quantitative and kinetic ch…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- NKp46+CD3+ cells as a Novel Target for Vaccines Against Bovine TB
- How they are buying
- The buyer did not say
- Type
- services
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 31 Mar 2016
- Work ends
- 3 Mar 2019
- Kind of work
- Research, evaluation and insight, Pharmacy and medicines
Who the buyer named
Emma Roberts was the named contact on this notice.
